Episode 25 - Charmaine Lykins, Commercial Strategy

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.We are thrilled to have Charmaine Lykins, Commercial Strategy Advisor at MapLight Therapeutics, join us.

Charmaine brings over 25 years of extensive experience in the commercial sector of psychiatry and neurology. Prior to MapLight, she was the Commercial Strategy Advisor at Karuna Therapeutics, where she spearheaded the commercial capabilities for the launch of KarXT in schizophrenia and Alzheimer's disease psychosis.

Charmaine's impressive career includes commercial strategy and execution for 10 product launches in the US and globally for CNS indications.

In this episode, we’ll dive into the resurgence of interest in neuro and CNS disorders, the importance of involving commercial teams early in development, and the challenges and rewards of bringing new treatments to market.

Enjoy and stay tuned